- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03999333
Virtual Reality in SOD
A Prospective Pilot Study to Evaluate the Effect of Virtual Reality as a Treatment Option for Pain in Patients With Functional Pancreaticobiliary Disorder or Type 3 Sphincter of Oddi Dysfunction
Patients with classic type-3 Sphincter of Oddi dysfunction have chronic debilitating pain not amenable to pharmacologic or endoscopic therapy. Previous studies have shown benefits of virtual reality (VR) for pain management through immersive three-dimensional (3D) multisensory experiences, but only in short-term inpatient settings.
The impact of VR for chronic pain in patients with SOD III in an outpatient setting is being evaluated in this pilot study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The pain management for type-3 Sphincter of Oddi dysfunction remains a significant clinical challenge and the current therapeutic outcome is often frustrating and may lead to addiction of opioid pain medication. Virtual reality (VR) has emerged as a viable option for pain management, but its usage has been limited to short-term inpatient clinical trials or experimental settings. In the proposed study, we will determine the long-term efficacy of VR intervention on pain management in patients with SOD type 3.
The study involves an initial screening visit and one follow-up visit at the end of the 6-week study.
The participants will receive self administered VR intervention, in additional to standard-of-care treatment for pain. The study also includes 6 weeks of monitoring period (2 weeks before, 4 weeks during, and 2 weeks after the VR intervention).
If the aims of the research are achieved, the study will demonstrate that virtual reality intervention may be used as a new method for pain management. This may lead to reduction in usage of opioid pain medication.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Liliana C Bancila, PhD
- Phone Number: 310.423-3872
- Email: Liliana.Bancila@cshs.org
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Recruiting
- Cedars-Sinai Medical Center
-
Contact:
- Simon Lo
- Phone Number: 310-423-6082
- Email: simon.lo@cshs.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of chronic biliary type abdominal pain (RUQ pain, pain radiates to the right flank, scapula, or shoulder, or pain that stimulates gallbladder symptoms)
- Pancreatic pain (epigastric or left upper quadrant pain, pain that is exacerbated by some food, or pain that radiates to the back) for at least 3 months prior to the study
- absence of abnormal liver and pancreas chemistry or abnormal abdominal imaging
- average pain score of greater than or equal to 3 out of 10 on the numeric rating scale (NRS) for at least the average of 3 episodes each week
- Subjects on antidepressants for pain control should take the medication for a minimum of one month prior to the baseline assessment.
- Patients with SOD with depressive and/or anxiety disorders who receive psychopharmacologic treatment must be on stable medication dose for at least 6 weeks.
- Patients with access to a cell phone, able to speak, read, and write English will be enrolled.
Exclusion Criteria:
- Patients with evidence for acute or chronic pancreatitis, biliary stones, or bile duct strictures.
- Patients who have had prior sphincterotomy must have had the procedure at 3 months prior to the start of the study.
- Patients with a history of motion sickness and vertigo and anyone experiencing active nausea or vomiting (including pregnant women) will be excluded.
- Patients with a history of seizures or epilepsy will also be excluded to limit the theoretical risk of inducing seizures with VR.
- Presence of significant psychiatric disorders or any conditions that, in the investigator's opinion make the subject unsuitable for study participation will be reason for exclusion.
- Non-English speaking subjects or subjects unable to consent to study due to cognitive difficulty will not be included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality
Every participant is provided with a VR headset
|
Participants will self-administer virtual reality intervention, in addition to standard of care treatment for pain.
There will be 6 weeks of weeks of monitoring period (2 weeks before, 4 weeks during, and 2 weeks after the virtual reality intervention).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain scores
Time Frame: 6 weeks
|
Pain scores will be measured using the Numeric Rating Scale (NRS) for at least 3 episodes each week.
The NRS measures pain on a scale of 0 to 10, with 0 signifying no pain and 10 signifying the worst possible pain.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Simon Lo, MD, Cedars-Sinai Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO00057560
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sphincter of Oddi Dysfunction
-
xpgengNot yet recruitingSphincter of Oddi Laxity
-
Peking University Third HospitalUnknown
-
TingBo LiangUnknownHepatolithiasis | Sphincter of Oddi LaxityChina
-
Medical University of South CarolinaCompletedSphincter of Oddi DysfunctionUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedSphincter of Oddi DysfunctionUnited States
-
University of NottinghamCompletedSphincter of Oddi DysfunctionUnited Kingdom
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownSphincter of Oddi DysfunctionChina
-
Peking University Third HospitalUnknownSphincter of Oddi FunctionChina
-
Gangnam Severance HospitalCompletedPancreatic Diseases | Sphincter of Oddi Dysfunction | Biliary Stricture | Malignant Hepatobiliary Neoplasm | Common Bile Duct StoneKorea, Republic of
-
Wisconsin Center for Advanced ResearchAurora Health CareTerminatedAbdominal Pain | Sphincter of Oddi DysfunctionUnited States
Clinical Trials on Virtual Reality (Oculus Go)
-
Johns Hopkins UniversityThe Thomas Wilson Sanitarium for Children of Baltimore CityTerminated
-
University Health Network, TorontoMichael Garron Hospital; Centre for Aging and Brain Health InnovationTerminatedDementia | Delirium Superimposed on DementiaCanada
-
Prisma Health-UpstateClemson UniversityCompletedBreast Neoplasm FemaleUnited States
-
Prisma Health-UpstateClemson UniversityCompleted
-
Radboud University Medical CenterCompletedPain | Pain Management | Post-surgical PainNetherlands
-
Stanford UniversityLucile Packard Children's HospitalCompletedPelvic Floor Disorders | Functional ConstipationUnited States
-
Cedars-Sinai Medical CenterRecruiting
-
University of MiamiWithdrawn
-
University of California, DavisRecruiting
-
VA Office of Research and DevelopmentCompleted